Literature DB >> 14198898

INDUCTION OF ACQUIRED RESISTANCE IN GUINEA PIGS WITH DEFATTED MYCOBACTERIUM TUBERCULOSIS VACCINES.

D W SMITH, G B FREGNAN, L DELAQUERRIERE, E VALDIVIA.   

Abstract

Smith, D. W. (University of Wisconsin, Madison), G. B. Fregnan, L. DeLaquerriere-Richardson, and E. Valdivia. Induction of acquired resistance in guinea pigs with defatted Mycobacterium tuberculosis vaccines. J. Bacteriol. 88:87-92. 1964.-Residues of mycobacteria exhaustively extracted with neutral organic solvents have been shown to produce a level of resistance against tuberculosis in guinea pigs comparable to that produced by BCG. Disruption of defatted tubercle bacilli in adjuvant eliminated the acid-fast staining property of the residue, but immunizing and sensitizing properties were retained in the fraction which sedimented at 44,000 x g. To demonstrate these activities with 50 mug of vaccine, it was necessary to use Bayol-Arlacel adjuvant. A similar quantity of vaccine given in saline was inactive. A defatted vaccine prepared from a virulent strain of Mycobacterium tuberculosis recently passed through a guinea pig was significantly more immunogenic than a similar vaccine prepared from H37Ra.

Entities:  

Keywords:  EXPERIMENTAL LAB STUDY; GUINEA PIGS; TUBERCULOSIS IMMUNITY; TUBERCULOSIS VACCINES

Mesh:

Substances:

Year:  1964        PMID: 14198898      PMCID: PMC277260          DOI: 10.1128/jb.88.1.87-92.1964

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  9 in total

1.  Immunogenicity and allergenioity in guinea pigs of a defatted mycobacterial vaccine and its fractions.

Authors:  G B FREGNAN; D W SMITH
Journal:  Am Rev Respir Dis       Date:  1963-06

2.  Immunogenicity of defatted mycobacteria in guinea pigs.

Authors:  R L ERIKSON; D W SMITH
Journal:  Am Rev Respir Dis       Date:  1962-03

3.  Vaccination against tuberculosis with nonliving vaccines. 3. Vaccination of guinea pigs with fractions of phenol-killed tubercle bacilli.

Authors:  D W WEISS; A Q WELLS
Journal:  Am Rev Respir Dis       Date:  1960-09

4.  Some biologic properties of myobacteria following the extraction of lipids; the power to initiate acquired resistance.

Authors:  A FRAPPIER; V PORTELANCE; J ST PIERRE
Journal:  Am Rev Tuberc       Date:  1959-03

5.  On the fractionation of complex components of Mycobacterium tuberculosis and their biological properties.

Authors:  T TSUMITA; T AOYAGI; R MATSUMOTO; E KONDO; D MIZUNO; H TAKAHASHI
Journal:  Jpn J Med Sci Biol       Date:  1960-06

6.  Allergenicity of intracellular particles, cell walls, and cytoplasmic fluid from Mycobacterium tuberculosis.

Authors:  K KANAI; G P YOUMANS; A S YOUMANS
Journal:  J Bacteriol       Date:  1960-11       Impact factor: 3.490

7.  The staining properties of isolated mycobacterial cellular components as revealed by the Ziehl-Neelsen procedure.

Authors:  K KANAI
Journal:  Am Rev Respir Dis       Date:  1962-03

8.  Studies on the cell-wall composition and taxonomy of Actinomycetales and related groups.

Authors:  C S CUMMINS; H HARRIS
Journal:  J Gen Microbiol       Date:  1958-02

9.  A mechanical cell disintegrator.

Authors:  P M NOSSAL
Journal:  Aust J Exp Biol Med Sci       Date:  1953-12
  9 in total
  3 in total

1.  Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals.

Authors:  D W Smith; E Wiegeshaus; R Navalkar; A A Grover
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

2.  Kinetics of the immune response profile in guinea pigs after vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.

Authors:  Ajay Grover; Jennifer Taylor; JoLynn Troudt; Andrew Keyser; Kimberly Arnett; Linda Izzo; Drew Rholl; Angelo Izzo
Journal:  Infect Immun       Date:  2009-09-08       Impact factor: 3.441

3.  The lipid substances and cytopathic effects in man of BCG strain "Copenhagen" and attenuated vole bacillus strain "Prague".

Authors:  L Sula; J Galliová; R Skrivanova
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.